NM_201384.3:c.4351G>A

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_201384.3(PLEC):​c.4351G>A​(p.Glu1451Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000658 in 1,579,770 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1451G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00072 ( 2 hom., cov: 35)
Exomes 𝑓: 0.00065 ( 2 hom. )

Consequence

PLEC
NM_201384.3 missense

Scores

1
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:2

Conservation

PhyloP100: 7.70

Publications

2 publications found
Variant links:
Genes affected
PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]
PLEC Gene-Disease associations (from GenCC):
  • PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • epidermolysis bullosa simplex
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • epidermolysis bullosa simplex 5A, Ogna type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • autosomal recessive limb-girdle muscular dystrophy type 2Q
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • congenital myasthenic syndrome
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • epidermolysis bullosa simplex 5B, with muscular dystrophy
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • epidermolysis bullosa simplex 5C, with pyloric atresia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • aplasia cutis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cholestasis
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.110022515).
BP6
Variant 8-143925578-C-T is Benign according to our data. Variant chr8-143925578-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 282780.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000722 (110/152300) while in subpopulation AMR AF = 0.00366 (56/15308). AF 95% confidence interval is 0.00289. There are 2 homozygotes in GnomAd4. There are 64 alleles in the male GnomAd4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLEC
NM_201384.3
MANE Select
c.4351G>Ap.Glu1451Lys
missense
Exon 31 of 32NP_958786.1Q15149-4
PLEC
NM_201378.4
MANE Plus Clinical
c.4309G>Ap.Glu1437Lys
missense
Exon 31 of 32NP_958780.1Q15149-9
PLEC
NM_201380.4
c.4762G>Ap.Glu1588Lys
missense
Exon 31 of 32NP_958782.1Q15149-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLEC
ENST00000345136.8
TSL:1 MANE Select
c.4351G>Ap.Glu1451Lys
missense
Exon 31 of 32ENSP00000344848.3Q15149-4
PLEC
ENST00000356346.7
TSL:1 MANE Plus Clinical
c.4309G>Ap.Glu1437Lys
missense
Exon 31 of 32ENSP00000348702.3Q15149-9
PLEC
ENST00000322810.8
TSL:1
c.4762G>Ap.Glu1588Lys
missense
Exon 31 of 32ENSP00000323856.4Q15149-1

Frequencies

GnomAD3 genomes
AF:
0.000723
AC:
110
AN:
152186
Hom.:
2
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00366
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000647
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000608
AC:
113
AN:
185844
AF XY:
0.000645
show subpopulations
Gnomad AFR exome
AF:
0.000286
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.000113
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000709
Gnomad OTH exome
AF:
0.00121
GnomAD4 exome
AF:
0.000651
AC:
929
AN:
1427470
Hom.:
2
Cov.:
61
AF XY:
0.000637
AC XY:
452
AN XY:
709172
show subpopulations
African (AFR)
AF:
0.0000608
AC:
2
AN:
32906
American (AMR)
AF:
0.00116
AC:
49
AN:
42298
Ashkenazi Jewish (ASJ)
AF:
0.000156
AC:
4
AN:
25682
East Asian (EAS)
AF:
0.0000261
AC:
1
AN:
38386
South Asian (SAS)
AF:
0.000441
AC:
37
AN:
83990
European-Finnish (FIN)
AF:
0.000221
AC:
8
AN:
36240
Middle Eastern (MID)
AF:
0.000876
AC:
5
AN:
5710
European-Non Finnish (NFE)
AF:
0.000700
AC:
772
AN:
1102842
Other (OTH)
AF:
0.000858
AC:
51
AN:
59416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
65
130
196
261
326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000722
AC:
110
AN:
152300
Hom.:
2
Cov.:
35
AF XY:
0.000859
AC XY:
64
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41574
American (AMR)
AF:
0.00366
AC:
56
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000647
AC:
44
AN:
67998
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000538
Hom.:
0
Bravo
AF:
0.000884
ExAC
AF:
0.000485
AC:
56
Asia WGS
AF:
0.000289
AC:
1
AN:
3474

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
2
not provided (4)
-
1
-
Autosomal recessive limb-girdle muscular dystrophy type 2Q (1)
-
1
-
Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy (1)
-
1
-
PLEC-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.29
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
7.7
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.22
Sift
Benign
0.086
T
Sift4G
Uncertain
0.019
D
Polyphen
1.0
D
Vest4
0.60
MutPred
0.24
Gain of ubiquitination at E1588 (P = 0.0198)
MVP
0.66
ClinPred
0.12
T
GERP RS
4.4
Varity_R
0.20
gMVP
0.78
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs868906137; hg19: chr8-144999746; API